Additional 5 Years of AI Treatment Reduces Distant Recurrence Rates Among Postmenopausal Women Already Treated with at Least 5 Years of Endocrine Therapy By Ogkologos - August 25, 2025 495 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a meta-analysis performed by the Early Breast Cancer Trialists’ Collaborative Group Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR Immunotherapy approved for some people with advanced melanoma in England December 21, 2021 Adding Atezolizumab to Chemotherapy Does Not Improve Outcomes in Patients Who... June 4, 2024 Enhertu Marks First Targeted Therapy for HER2-Mutant Lung Cancer September 13, 2022 Blinatumomab Increases Survival for Infants with an Aggressive Type of ALL June 8, 2023 Load more HOT NEWS Study Adds to Debate about Screening for Melanoma Learning From Being Lost Adding One Year of Palbociclib to Adjuvant Endocrine Treatment Does Not... Exceptional Response to Single-Agent Anti-PD1 Therapy Observed in Patients with Advanced...
